Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
complaint of sexual dysfunction and metabolic syndrome are highly reported in men with psoriasis
erectile dysfunction (ED) psoriatic men with metabolic syndrome (number of the patients will be 60) will assigned to study group (group = 30 patients) that will receive lifestyle changes (12 weeks of low calorie diet and moderate-intensity walking on treadmill, the walking duration will be 40 minutes, the walking will be three times per week) or control group (group=30 patients) that will receive no lifestyle changes/modifications.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| lifestyle-modification group | Experimental | erectile dysfunction (ED) psoriatic men with metabolic syndrome (group = 30 patients) will receive lifestyle changes (12 weeks of low calorie diet and moderate-intensity walking on treadmill, the walking duration will be 40 minutes, the walking will be three times per week) |
|
| control group | No Intervention | erectile dysfunction (ED) psoriatic men with metabolic syndrome (number of the patients will be 30) that will receive no lifestyle changes/modifications. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| lifestyle modification (exercise and control of diet) | Behavioral | erectile dysfunction (ED) psoriatic men with metabolic syndrome that will receive lifestyle changes (12 weeks of low calorie diet and moderate-intensity walking on treadmill, the walking duration will be 40 minutes, the walking will be three times per week) |
| Measure | Description | Time Frame |
|---|---|---|
| International Index of Erectile Function | Arabic version of this 5-item questionnaire will used to assess erectile function/dysfunction | It will be measured after 12-week intervention |
| Measure | Description | Time Frame |
|---|---|---|
| psoriasis area and severity index | it is a tool used to measure the severity and extent of psoriasis. | It will be measured after 12-week intervention |
| body mass index | patients will be assessed with empty bowel and bladder |
Not provided
Inclusion Criteria:
Exclusion Criteria:
based on self-representation of gender identity
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ali Ismail, lecturer | Contact | 02 01005154209 | ali.mohamed@pt.cu.edu.eg |
| Name | Affiliation | Role |
|---|---|---|
| Ali Ismail, lecturer | Cairo University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cairo Unoversity | Recruiting | Giza | Egypt |
Not provided
| ID | Term |
|---|---|
| D011565 | Psoriasis |
| D024821 | Metabolic Syndrome |
| D007172 | Erectile Dysfunction |
| ID | Term |
|---|---|
| D017444 | Skin Diseases, Papulosquamous |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D007333 | Insulin Resistance |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| It will be measured after 12-week intervention |
| systolic blood pressure | it will be measured using sphygmomanometer | It will be measured after 12-week intervention |
| diastolic blood presure | it will be measured using sphygmomanometer | It will be measured after 12-week intervention |
| waist circumference | it will be measured by in elastic tape | It will be measured after 12-week intervention |
| blood glucose | it will be measured in fasting status | It will be measured after 12-week intervention |
| triglycerides | it will be measured in serum | It will be measured after 12-week intervention |
| high density lipoprotein | it will be measured in serum | It will be measured after 12-week intervention |
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D005832 | Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D012735 | Sexual Dysfunction, Physiological |
| D052801 | Male Urogenital Diseases |
| D020018 | Sexual Dysfunctions, Psychological |
| D001523 | Mental Disorders |